Fallon, James S. – Trademark Portfolio

Entity Type: 01

Fallon, James S. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SNORERX, MICRO-FIT, MICRO-ADJUST, and ASEPTIC GUARD. The owner is based in Laguna Niguel, CA.

17 Brownsbury Road

Laguna Niguel, CA 92677

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Fallon, James S.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Fallon, James S. have?

Fallon, James S. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 5 abandoned, 1 cancelled.

What trademark classes does Fallon, James S. file in?

Fallon, James S. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Fallon, James S.'s most well-known trademarks?

Fallon, James S.'s registered trademark portfolio includes well-known marks such as SNORERX, MICRO-FIT, MICRO-ADJUST, and ASEPTIC GUARD. These are among 4 currently registered trademarks in the portfolio.

What is Fallon, James S.'s trademark registration success rate?

Fallon, James S. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.